219 related articles for article (PubMed ID: 28795996)
1. Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
Yu SJ; Kwon JH; Kim W; Yoon JH; Lee JM; Lee JY; Cho EJ; Lee JH; Kim HY; Jung YJ; Kim YJ
J Clin Gastroenterol; 2018 Mar; 52(3):e18-e26. PubMed ID: 28795996
[TBL] [Abstract][Full Text] [Related]
2. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
4. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
5. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
Kim JS; Kim W; So YH; Yu SJ; Kim BG
J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
[TBL] [Abstract][Full Text] [Related]
6. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
7. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
[TBL] [Abstract][Full Text] [Related]
9. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
10. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
11. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
[TBL] [Abstract][Full Text] [Related]
13. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
[TBL] [Abstract][Full Text] [Related]
15. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
16. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
19. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Lee JS; Chon YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kang W; Choi MS; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Kim HY; Kim TH; Yoo K; Ha Y; Kim MN; Lee JH; Hwang SG; Kim SS; Cho HJ; Cheong JY; Cho SW; Park SH; Heo NY; Hong YM; Yoon KT; Cho M; Park JG; Kang MK; Park SY; Kweon YO; Tak WY; Jang SY; Sinn DH; Kim SU;
Yonsei Med J; 2021 Jan; 62(1):12-20. PubMed ID: 33381930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
